Delivery Order SPE2DB20D3103-SPE2DB25FQ0B8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10.7K to AmerisourceBergen Drug Corp for Topamax 200 mg tablets (60-count units) on August 25, 2025, with completion targeted for August 26, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,709.26 to AmerisourceBergen Drug Corp for 60 tablets of Topamax 200 mg, a pharmaceutical product used primarily for migraine prevention and seizure management. The award, issued on July 22, 2025, utilizes firm fixed price terms with an ultimate completion date of July 23, 2025. This is a competitively awarded, non-set-aside contract with performance to take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,045.60 to AmerisourceBergen Drug Corp for 60 tablets of Topamax 25 mg. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order represents a discrete transaction under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Topamax (topiramate) 50 mg tablets in quantities of 60 units, with a ceiling value of $3,052.09. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is scheduled for ultimate completion by July 31, 2025, and represents a short-duration fulfillment of pharmaceutical requirements for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Topamax 100 mg tablets in a quantity of 60 units, with a ceiling value of $19,206.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The vendor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,558.94 to AmerisourceBergen Drug Corp for the supply of Topamax 25 mg sprinkle capsules (60-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Topamax 25 mg sprinkle capsules (60 count) with a ceiling value of $2,914.86. This firm fixed-price contract utilizes no set-aside provisions and reflects competitive procurement practices. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $24,597.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Topamax 50 mg tablets. This contract is a task order issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to supply...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,942.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 60-count bottles of Topamax 100 mg tablets. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
- The Defense Logistics Agency awarded a $3,032 delivery order contract to Amerisourcebergen Drug Corporation to supply Topamax 25mg tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 count bottles of the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania between September 8-11, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen routinely supports the DLA's mission to provide medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0B8Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,819.25 on August 25, 2025, for the supply of Topamax 200 mg tablets (60-count units). This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the place of performance. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. This prime vendor contract enables the pharmaceutical distributor to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contracting history demonstrates its role as a critical vendor for the Defense Health Agency and other government healthcare systems, with consistent delivery orders for brand-name and generic pharmaceuticals across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/25/25 |